Last reviewed · How we verify

NCT06000930: MaraCat2

Cardiac Troponin Fragmentation After Heavy Physical Exercise The MaraCat2 Study

ENROLLING BY INVITATION Last updated 8 May 2024
What this trial tests

trial testing Troponin fragmentation in Myocardial Infarction in 170 participants. Enrolling by invitation.

Timeline
19 August 2023
Primary endpoint
1 September 2024
1 September 2024

Quick facts

Lead sponsorUniversity of Turku
StatusENROLLING BY INVITATION
Study typeOBSERVATIONAL
Enrollment170
Start date19 August 2023
Primary completion1 September 2024
Estimated completion1 September 2024
Sites1 location across Finland

Drugs / interventions tested

Conditions studied

Sponsor

University of Turku

Who can join

Adults 18 to 80, any sex, with Myocardial Infarction or Myocardial Injury. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Cardiac troponins are highly sensitive and specific biomarkers of cardiac injury and are in a key role in the diagnosis of acute myocardial infarction (MI). Minor troponin elevations are common after prolonged strenuous exercise without clinical symptoms of MI or myocardial injury. Importantly, currently used high-sensitivity troponin T (cTnT) test detects also smaller troponin fragments which may cause troponin elevation after exercise and lead to false diagnosis of MI. In the present study protocol, we compare the characteristics troponin release after marathon race and Type 1 MI with the improved version of our novel troponin fragmentation test (SuperTropo test) and the commercial cTnT test. A total of 65 recreational runners participating in the 2023 Paavo Nurmi Marathon in Turku are recruited. All participants give a blood sample during the post-race visit (within 30 min after finishing the marathon). A control group of 90 patients with acute Type 1 MI are recruited among patients admitted to Heart Centre of Turku University Hospital. Commercial cTnT and long troponin component of cTnT analyzed witha novel immunoassay are dtermined in all subjects to assess cTnT fragmentation. TYhe main aims of the study are: To assess how often cTnT is elevated after marathon running and which factors affect the cTnT rise? Is the fragmentation of troponin more common after marathon race compared with Type 1 MI and can the novel Supertropo test separate execise-induced troponin rise from those caused by MI ?

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Composition of cardiac troponin release differs after marathon running and myocardial infarction.
    Airaksinen KEJ, Paana T, Vasankari T, Salonen S, et al · · 2024 · cited 11× · PMID 39551608 · DOI 10.1136/openhrt-2024-002954
  2. Cardiac Troponin Fragmentation After Heavy Physical Exercise The MaraCat2 Study
    Airaksinen KEJ, Paana T, Hellman T, Vasankari T, et al · · 2024 · DOI 10.1101/2024.05.07.24307024

Verify or expand the search:

Other recruiting trials for Myocardial Infarction

Currently open trials in the same condition.

Other University of Turku trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06000930.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing